Axiom Investors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-27,022
Closed -$2.29M 125
2019
Q3
$2.29M Buy
27,022
+14,627
+118% +$1.3M 0.06% 93
2019
Q2
$1.3M Sell
12,395
-20,569
-62% -$2.07M 0.04% 113
2019
Q1
$3.48M Sell
32,964
-3,312
-9% -$333K 0.11% 81
2018
Q4
$3.04M Sell
36,276
-13,476
-27% -$1.22M 0.11% 92
2018
Q3
$5.07M Sell
49,752
-3,870
-7% -$374K 0.15% 82
2018
Q2
$4.34M Sell
53,622
-9,124
-15% -$725K 0.13% 94
2018
Q1
$4.62M Buy
62,746
+1,279
+2% +$95.7K 0.11% 91
2017
Q4
$4.33M Buy
61,467
+25,172
+69% +$1.82M 0.11% 94
2017
Q3
$2.27M Sell
36,295
-7,195
-17% -$426K 0.05% 115
2017
Q2
$2.5M Sell
43,490
-27,155
-38% -$1.6M 0.06% 115
2017
Q1
$4.3M Sell
70,645
-29,013
-29% -$1.64M 0.11% 84
2016
Q4
$5.47M Buy
99,658
+52,451
+111% +$2.52M 0.16% 74
2016
Q3
$2.18M Buy
+47,207
New +$1.99M 0.06% 78

Other funds holding NGVT

Axiom Investors's NGVT Position: Q4 2019 in Review

Axiom Investors sold out of Ingevity (NGVT) in Q4 2019, closing a stake of 27,022 shares — an estimated $2.29M sold.

Axiom Investors first reported a position in NGVT in Q3 2016 and held it in 13 quarters. The position peaked at $5.47M in Q4 2016. 334 funds tracked by Wall St. Rank hold NGVT as of Q4 2019.

  • Axiom Investors reported no remaining Ingevity position as of Q4 2019 after selling out during the quarter.
  • Axiom Investors sold 27,022 Ingevity shares in Q4 2019, an estimated $2.29M.
  • Axiom Investors first reported a position in Ingevity in Q3 2016 and held it in 13 quarters.
  • Axiom Investors's Ingevity position peaked at $5.47M in Q4 2016.
  • 334 funds tracked by Wall St. Rank held Ingevity as of Q4 2019.

Based on Axiom Investors's 13F filing for Q4 2019, filed 13 Feb 2020.